Research Library — Page 90 | Reta Compare
3563 research articles. Page 90 of 143.
Articles
- Partial Reprogramming: A Novel Approach to Epigenetic Rejuvenation in Aging Research
- Partial Reprogramming: Epigenetic Insights into Aging and Tissue Rejuvenation
- Partial Reprogramming: Evaluating Chemical Approaches to Cellular Aging
- Partial Reprogramming: New Imaging Biomarker for Assessing Biological Age
- Partial Reprogramming: Insights from Insect to Mammal in Aging Research
- Partial Reprogramming: A Novel Approach to Enhance Organ Quality and Longevity
- Partial Reprogramming Enhances Peripheral Nerve Regeneration in Aged Schwann Cells
- Partial Reprogramming: A Novel Approach to Reverse Mesenchymal Drift in Aging
- Partial Reprogramming: A Novel Approach to Rejuvenate Aged Cells
- Partial Reprogramming: Insights from Long Noncoding RNAs in Pancreatic Cancer
- Partial Reprogramming: A Pathway to Combat Aging and Osteoarthritis
- Partial Reprogramming with Oxytocin and A5i Extends Lifespan in Male Mice
- Partial Reprogramming: A Chemical Approach to Combat Aging and Extend Lifespan
- Exploring Partial Reprogramming: Advancements in Aging Research through Microfluidics
- Partial Reprogramming: A Potential Pathway to Age Reversal
- Partial Reprogramming: Evaluating Chemical Approaches to Cellular Rejuvenation
- Partial Reprogramming: Small Molecule Combinations Enhance Lifespan in Aging Mice
- Rapamycin Derivative Shows Promise for Longevity in Caenorhabditis elegans
- Rapamycin and ER-Phagy: Insights into Longevity Mechanisms
- Rapamycin and the Role of PITP-1 in Longevity Regulation
- Sirolimus and mTOR Inhibition: Implications for Cardiac Xenotransplant Longevity
- Rapamycin Longevity: Insights from Super Seniors and Genetic Pathways
- Nitric Oxide-Releasing Hydrogel Enhances Bioprosthetic Valve Longevity
- Rapamycin Longevity: Insights from Cancer-Neurodegeneration Pathways
- Rapamycin Longevity: A Unified Redox Framework for Multi-Disease Prevention